147 related articles for article (PubMed ID: 28881750)
1. New
Plessier A; Le Dret L; Varlet P; Beccaria K; Lacombe J; Mériaux S; Geffroy F; Fiette L; Flamant P; Chrétien F; Blauwblomme T; Puget S; Grill J; Debily MA; Castel D
Oncotarget; 2017 Aug; 8(32):52543-52559. PubMed ID: 28881750
[TBL] [Abstract][Full Text] [Related]
2. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma.
Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E
J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423
[TBL] [Abstract][Full Text] [Related]
3. Current Murine Models and New Developments in H3K27M Diffuse Midline Gliomas.
Welby JP; Kaptzan T; Wohl A; Peterson TE; Raghunathan A; Brown DA; Gupta SK; Zhang L; Daniels DJ
Front Oncol; 2019; 9():92. PubMed ID: 30873381
[TBL] [Abstract][Full Text] [Related]
4. Patient-derived DIPG cells preserve stem-like characteristics and generate orthotopic tumors.
Xu C; Liu X; Geng Y; Bai Q; Pan C; Sun Y; Chen X; Yu H; Wu Y; Zhang P; Wu W; Wang Y; Wu Z; Zhang J; Wang Z; Yang R; Lewis J; Bigner D; Zhao F; He Y; Yan H; Shen Q; Zhang L
Oncotarget; 2017 Sep; 8(44):76644-76655. PubMed ID: 29100338
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic inhibition of lysine-specific demethylase 1 as a therapeutic and immune-sensitization strategy in pediatric high-grade glioma.
Bailey CP; Figueroa M; Gangadharan A; Yang Y; Romero MM; Kennis BA; Yadavilli S; Henry V; Collier T; Monje M; Lee DA; Wang L; Nazarian J; Gopalakrishnan V; Zaky W; Becher OJ; Chandra J
Neuro Oncol; 2020 Sep; 22(9):1302-1314. PubMed ID: 32166329
[TBL] [Abstract][Full Text] [Related]
6. Diffuse Intrinsic Pontine Glioma: Molecular Landscape, Evolving Treatment Strategies and Emerging Clinical Trials.
Damodharan S; Lara-Velazquez M; Williamsen BC; Helgager J; Dey M
J Pers Med; 2022 May; 12(5):. PubMed ID: 35629262
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of microglial EZH2 leads to anti-tumoral effects in pediatric diffuse midline gliomas.
Keane L; Cheray M; Saidi D; Kirby C; Friess L; Gonzalez-Rodriguez P; Gerdes ME; Grabert K; McColl BW; Joseph B
Neurooncol Adv; 2021; 3(1):vdab096. PubMed ID: 34485907
[TBL] [Abstract][Full Text] [Related]
8. Biopsy in a series of 130 pediatric diffuse intrinsic Pontine gliomas.
Puget S; Beccaria K; Blauwblomme T; Roujeau T; James S; Grill J; Zerah M; Varlet P; Sainte-Rose C
Childs Nerv Syst; 2015 Oct; 31(10):1773-80. PubMed ID: 26351229
[TBL] [Abstract][Full Text] [Related]
9. Deceptive morphologic and epigenetic heterogeneity in diffuse intrinsic pontine glioma.
Bugiani M; Veldhuijzen van Zanten SEM; Caretti V; Schellen P; Aronica E; Noske DP; Vandertop WP; Kaspers GJL; van Vuurden DG; Wesseling P; Hulleman E
Oncotarget; 2017 Sep; 8(36):60447-60452. PubMed ID: 28947983
[TBL] [Abstract][Full Text] [Related]
10. A Protocol for the Generation of Treatment-naïve Biopsy-derived Diffuse Intrinsic Pontine Glioma and Diffuse Midline Glioma Models.
Biery MC; Noll A; Myers C; Morris SM; Winter CA; Pakiam F; Cole BL; Browd SR; Olson JM; Vitanza NA
J Exp Neurol; 2020 Dec; 1(4):158-167. PubMed ID: 33768215
[TBL] [Abstract][Full Text] [Related]
11. Pre-Clinical Models of Diffuse Intrinsic Pontine Glioma.
Misuraca KL; Cordero FJ; Becher OJ
Front Oncol; 2015; 5():172. PubMed ID: 26258075
[TBL] [Abstract][Full Text] [Related]
12. Implementation of a multi-institutional diffuse intrinsic pontine glioma autopsy protocol and characterization of a primary cell culture.
Caretti V; Jansen MH; van Vuurden DG; Lagerweij T; Bugiani M; Horsman I; Wessels H; van der Valk P; Cloos J; Noske DP; Vandertop WP; Wesseling P; Wurdinger T; Hulleman E; Kaspers GJ
Neuropathol Appl Neurobiol; 2013 Jun; 39(4):426-36. PubMed ID: 22845849
[TBL] [Abstract][Full Text] [Related]
13. Children are not just little adults: recent advances in understanding of diffuse intrinsic pontine glioma biology.
Schroeder KM; Hoeman CM; Becher OJ
Pediatr Res; 2014 Jan; 75(1-2):205-9. PubMed ID: 24192697
[TBL] [Abstract][Full Text] [Related]
14. Intranasal delivery of nanoliposomal SN-38 for treatment of diffuse midline glioma.
Sasaki T; Watanabe J; He X; Katagi H; Suri A; Ishi Y; Abe K; Natsumeda M; Frey WH; Zhang P; Hashizume R
J Neurosurg; 2023 Jun; 138(6):1570-1579. PubMed ID: 36599085
[TBL] [Abstract][Full Text] [Related]
15. Spatial genomic heterogeneity in diffuse intrinsic pontine and midline high-grade glioma: implications for diagnostic biopsy and targeted therapeutics.
Hoffman LM; DeWire M; Ryall S; Buczkowicz P; Leach J; Miles L; Ramani A; Brudno M; Kumar SS; Drissi R; Dexheimer P; Salloum R; Chow L; Hummel T; Stevenson C; Lu QR; Jones B; Witte D; Aronow B; Hawkins CE; Fouladi M
Acta Neuropathol Commun; 2016 Jan; 4():1. PubMed ID: 26727948
[TBL] [Abstract][Full Text] [Related]
16. A standardized autopsy procurement allows for the comprehensive study of DIPG biology.
Kambhampati M; Perez JP; Yadavilli S; Saratsis AM; Hill AD; Ho CY; Panditharatna E; Markel M; Packer RJ; Nazarian J
Oncotarget; 2015 May; 6(14):12740-7. PubMed ID: 25749048
[TBL] [Abstract][Full Text] [Related]
17. Robot-Assisted Stereotactic Biopsy of Diffuse Intrinsic Pontine Glioma: A Single-Center Experience.
Carai A; Mastronuzzi A; De Benedictis A; Messina R; Cacchione A; Miele E; Randi F; Esposito G; Trezza A; Colafati GS; Savioli A; Locatelli F; Marras CE
World Neurosurg; 2017 May; 101():584-588. PubMed ID: 28254596
[TBL] [Abstract][Full Text] [Related]
18. Spatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine glioma.
Nikbakht H; Panditharatna E; Mikael LG; Li R; Gayden T; Osmond M; Ho CY; Kambhampati M; Hwang EI; Faury D; Siu A; Papillon-Cavanagh S; Bechet D; Ligon KL; Ellezam B; Ingram WJ; Stinson C; Moore AS; Warren KE; Karamchandani J; Packer RJ; Jabado N; Majewski J; Nazarian J
Nat Commun; 2016 Apr; 7():11185. PubMed ID: 27048880
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathology of diffuse intrinsic pontine glioma and its redefined genomic and epigenomic landscape.
Panditharatna E; Yaeger K; Kilburn LB; Packer RJ; Nazarian J
Cancer Genet; 2015; 208(7-8):367-73. PubMed ID: 26206682
[TBL] [Abstract][Full Text] [Related]
20. A high-throughput in vitro drug screen in a genetically engineered mouse model of diffuse intrinsic pontine glioma identifies BMS-754807 as a promising therapeutic agent.
Halvorson KG; Barton KL; Schroeder K; Misuraca KL; Hoeman C; Chung A; Crabtree DM; Cordero FJ; Singh R; Spasojevic I; Berlow N; Pal R; Becher OJ
PLoS One; 2015; 10(3):e0118926. PubMed ID: 25748921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]